Cargando…
Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine
Mesenchymal stem cells (MSCs) are in development for many clinical indications, based both on ‘stem’ properties (tissue repair or regeneration) and on signaling repertoire (immunomodulatory and anti-inflammatory effects). Potential conflation of MSC properties with those of tissue-derived stromal ce...
Autores principales: | Wilson, Alison, Webster, Andrew, Genever, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132560/ https://www.ncbi.nlm.nih.gov/pubmed/31115266 http://dx.doi.org/10.2217/rme-2018-0145 |
Ejemplares similares
-
Stem cell heterogeneity and regenerative competence: the enormous potential of rare cells
por: Gilbert, Emily A.B., et al.
Publicado: (2020) -
A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
por: Kurtz, Andreas, et al.
Publicado: (2018) -
The Missing ‐Omes: Proposing Social and Environmental Nomenclature in Precision Medicine
por: Davis, MM, et al.
Publicado: (2017) -
Mesenchymal Stem Cells and Regenerative Medicine
por: Sumer, Huseyin, et al.
Publicado: (2018) -
Mesenchymal Stem Cells for Regenerative Medicine
por: Han, Yu, et al.
Publicado: (2019)